Filing Details
- Accession Number:
- 0000899243-22-035311
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-07 20:19:13
- Reporting Period:
- 2022-11-03
- Accepted Time:
- 2022-11-07 20:19:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1880438 | An2 Therapeutics Inc. | ANTX | Pharmaceutical Preparations (2834) | 820606654 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1914503 | Eric Easom | C/O An2 Therapeutics, Inc. 1800 El Camino Real, Suite D Menlo Park CA 94027 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-03 | 11,082 | $15.67 | 29,021 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-03 | 3,083 | $16.02 | 25,938 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-04 | 8,828 | $15.80 | 17,110 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-07 | 10,167 | $15.90 | 6,943 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-07 | 2,036 | $16.72 | 4,907 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Billionaire Hedge Funds
